Skip to main content

Table 4 Comparative analysis of the currently available vaccines.

From: Cross-species virus transmission and its pandemic potential

Name

Type

Efficacy (%)

Dosage

Storage

Country/origin

Covaxin

Inactivated virus vaccine

81

2 doses with a gap of 28 days in between

+ 2–8 °C

Bharat Biotech (India)

BBIBP—CorV

Inactivated virus vaccine

72–86

2 doses with a gap of 21 days in between

+ 2–8 °C

Sinopharm (China)

CoronaVac

Inactivated virus vaccine

50.7–83.7

2 doses with a gap of 14 days in between

+ 2–8 °C

SinoVac (China)

JNJ-78436735

Viral vector vaccine

72

1 dose

+ 2–8 °C for short-term storage and − 20 °C for long term storage

Johnson and Johnson (USA)

Sputnik V

Viral vector vaccine

91

2 doses with a gap of 21 days in between

+ 2–8 °C for short-term storage and − 20 °C for long term storage

Gamaleya (Russia)

Novavax

Virus-like particle vaccine

96

2 doses with a gap of 21 days in between

+ 2–8 °C for short-term storage and − 20 °C for long term storage

(USA)

Covishield

Viral vector vaccine

70–82

2 doses with a gap of upto 12 weeks in between

+ 2–8 °C

Oxford/Astrazneca (UK and Sweden)

BioNTech/Pfizer

Encapsulated mRNA vaccine

96

2 doses with a gap of 21 days in between

+ 2–8 °C for 5 days and − 70 °C for longer duration

(USA and Germany)

Moderna

Encapsulated mRNA vaccine

94.1

2 doses with a gap of 28 days in between

+ 2–8 °C for short-term storage and − 20 °C for long term storage

USA